Strasbourg, January 7, 2025 – 06:00 pm CET
Under the liquidity contract entrusted by Transgene to Natixis Oddo BHF SCA, as of December 31, 2024, the following resources were managed through the liquidity account:
In the second half of 2024, a total of:
Purchases | 250,777 shares | € 243,947.38 | 1,154 market transactions |
Sales | 229 905 shares | € 230,275.17 | 1,081 market transactions |
It is recalled that when the liquidity program was initially established in 2016, the following resources were made available:
At the time the liquidity program was transferred to Natixis Oddo BHF SCA on January 2, 2020, the resources managed through the liquidity account consisted of:
Contacts
Transgene: Lucie LARGUIER CFO +33 (0)3 88 27 91 00 investorrelations@transgene.fr |
Attachment
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。